Guide for Authors
Actas Urológicas Españolas is an international journal dedicated to urological diseases and renal transplant. It has been the official publication of the Spanish Urology Association since 1974 and of the American Urology Confederation since 2008. Its articles cover all aspects related to urology.
Actas Urológicas Españolas, governed by the peer review system (double blinded), is published online in Spanish and English. Consequently, manuscripts may be sent in Spanish or English and bidirectional free cost translation will be provided. It has high visibility and accessibility and is found in the most important data bases, Medline/Pubmed, Emabase, JCR, Índice Médico Español, Índice bibliográfico Español en Ciencias de la Salud (IBECS), Cuiden, Dialnet, Hinari, Scopus, Google Scholar.
We suggest that articles by Spanish authors should comply with the general criteria of Law 14/2007, from 3rd July, for biomedical research (BOE n 159), which protects the rights of individuals who are subjects of research. Clinical assays should be registered with public databases prior to their initiation and patient recruitment, and only after approval of the institutional or regional Clinical Research Ethics Committee. The authors should provide the archive number and database where the assay is registered. For all clinical assays that initiate patient recruitment as of 1 January 2017, registration in public databases will be mandatory. Assays with patient recruitment prior to this date may still be submitted to the Journal for evaluation.
EDITORIAL.Involve comments on Current Topics or on studies published in the same issue. The maximum length of the manuscript shall not exceed 1200 words, includig a maximum of 15 references. All Editorials shall be requested by the Journal’s Board and should not be sent without prior written approval. Opposing or complementary Editorials presenting different perspectives on the subject covered, might be given an option. Editorial comments on previously published articles and commissioned by the Journal's Board will also be published. These articles shall have a maximum of 250 words and 6 references.
ORIGINAL ARTICLE. Research studies on the following fields of urology will be considered: robotics, laparoscopy, basic research, clinical research, surgical techniques, imaging techniques, transplantation, oncology, endourology, urogynecology, quality of life, healthcare management, methodology, medical training and history. The recommended designs are analytical in the form of transverse or longitudinal surveys, case-control studies, cohort studies and controlled trials. Controlled clinical trials must follow the CONSORT legislation available at (="http://www.consort-statement.org" href="http://www.consort-statement.org, http://www.consort-statement.org; and for analytical and observational studies, the STROBE Statement (="http://www.strobe-statement.org/" href="http://www.strobe-statement.org/", http://www.strobe-statement.org/) must be used. Retrospective descriptive studies that do not include the appropriate statistical treatment will not be accepted.
The manuscript must not exceed 2500 words. The manuscript must also include an abstract, with no more than 250 words long, containing 3-6 keywords, up to 30 references, figure legends and tables. A maximum of 6 elements (tables and/or figures) per article will be accepted. The figures must be attached in color, in separate files, in TIFF format and at 300 dpi (never placed in a Microsoft Word, PowerPoint or similar document). Succinctness and proper writing of the articles are important.
REVIEW ARTICLE. These are articles that systematically show, select, critique and synthesize evidence related to well defined issues on current topics of urology (diagnostic, therapeutic and prognostic questions). All Review Articles shall be requested by the Journal’s Board. Authors who wish to write an article of this type should contact the Board directly and request permission before sending the manuscript.
Priority will be given to systematic reviews and meta-analysis, which have to be conducted and presented in adherence with the PRISMA statement recommendations (="http://prisma-statement.org/" href="http://prisma-statement.org/", http://prisma-statement.org/). Articles submitted in this format will be reviewed by the Board, by members of the Journal’s Editorial Committee and by other Reviewers.
The manuscript shall not exceed 3,500 words and must be drafted according to the sections included in this guide for authors, however, those sections whose inclusion the author considers necessary for a perfect understanding of the treated topic (Context, Objective, Acquisition of Evidence, Synthesis of Evidence, Conclusions) will be accepted. The abstract must be structured and with a maximum of 250 words. The manuscript must include 3-6 keywords; up to 40 references; as well as the figure legends and tables considered necessary. A maximum of 10 elements (tables and/or figures) will be accepted. The figures must be attached in color, in separate fi les, in TIFF format and at 300 dpi (never placed in a Microsoft Word, PowerPoint or similar document). Succinctness and proper writing of the articles are important.
SURGERY. In this section should be included those works developing new surgical techniques in Urology. Manuscript shall be original and cover current surgical issues. Merely descriptive studies that do not include personal or caseload experience with follow-up will not be accepted.
The manuscript must not exceed 2500 words in length and must be drafted according to the sections described in this guide for authors. The manuscript must include an abstract written in Spanish no more than 250 words long, with 3-6 keywords, up to 30 references, figure legends and tables. It is recommended that the number of signatories be restricted to no more than 6. Succinctness, clarity of presentation and proper writing of the articles are important. A maximum of 6 elements (tables and/or figures) per article will be accepted. The figures must be attached in color.
The article shall be accompanied by a video file in dynamic image format, with copyright-free music and voice-over in Spanish or English illustrating the principal stages of the technique. The video will include a maximum of 5-10 minutes’ filming to demonstrate the surgical procedure, with the different technical stages involved and the material required. The videos should be shown in either mpg or avi format and the size of the file must not exceed 50 MB. The audio voiceover will be copyright free. The patients’ right to privacy will be respected in all cases and they will have provided their informed consent to post the video on the website. This file will be available in the online version of the journal.
The articles will be requested by the Editor of the journal. If an author wishes to write an article of this type they should contact the Editor directly before submitting the manuscript. Articles presented in this format will also be reviewed according to the editorial process and might be rejected.
LETTER TO THE EDITOR. The articles included in this section might be free opinions or comments relating to articles recently published in the Journal and might provide replies or supplements to studies published in Actas Urológicas Españolas. The letters must be individually signed. In neither case the text of the letter will not exceed 500 words. Personal comments are to be avoided. Do not include abstracts or keywords. If images are needed, include only one per letter; the image must be in color, in TIFF format and at a minimum of 300 dpi. It is recommended that the letters be accompanied by references, although no more than 3.
Contact details for submission
You can send your manuscript at https://www.editorialmanager.com/acuro/
Page charges
This journal has no page charges.
Language
This journal is published in Spanish and in English language.
Submission checklist
You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
All necessary files have been uploaded:
Manuscript:
• Include keywords
• All figures (include relevant captions)
• All tables (including titles, description, footnotes)
• Ensure all figure and table citations in the text match the files provided
• Indicate clearly if color should be used for any figures in print
Graphical Abstracts / Highlights files (where applicable)
Supplemental files (where applicable)
Further considerations
• Manuscript has been 'spell checked' and 'grammar checked'
• All references mentioned in the Reference List are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Internet)
• A competing interests statement is provided, even if the authors have no competing interests to declare
• Journal policies detailed in this guide have been reviewed
• Referee suggestions and contact details provided, based on journal requirements
Ethics in publishing
Please see our information on Ethics in publishing.
Studies in humans and animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.
Informed consent and patient details
Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an Elsevier publication. Written consents must be retained by the author but copies should not be provided to the journal. Only if specifically requested by the journal in exceptional circumstances (for example if a legal issue arises) the author must provide copies of the consents or evidence that such consents have been obtained. For more information, please review the Elsevier Policy on the Use of Images or Personal Information of Patients or other Individuals. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.
Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
Preprints
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Clinical trial results
In line with the position of the International Committee of Medical Journal Editors, the journal will not consider results posted in the same clinical trials registry in which primary registration resides to be prior publication if the results posted are presented in the form of a brief structured (less than 500 words) abstract or table. However, divulging results in other circumstances (e.g., investors' meetings) is discouraged and may jeopardise consideration of the manuscript. Authors should fully disclose all posting in registries of results of the same or closely related work.
Reporting clinical trials
Randomized controlled trials should be presented according to the CONSORT guidelines. At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure. The CONSORT checklist and template flow diagram are available online.
Registration of clinical trials
Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors recommendations. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article. A clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioural treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases.
Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. More information.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Elsevier Researcher Academy
Researcher Academy is a free e-learning platform designed to support early and mid-career researchers throughout their research journey. The "Learn" environment at Researcher Academy offers several interactive modules, webinars, downloadable guides and resources to guide you through the process of writing for research and going through peer review. Feel free to use these free resources to improve your submission and navigate the publication process with ease.
Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's Author Services.
Submission
Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.
Submit your article
Please submit your article via https://www.editorialmanager.com/acuro/.
……
更多详情：
https://www.elsevier.com/journals/actas-urologicas-espanolas/0210-4806/guide-for-authors
